Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Through major histocompatibility complex class Ia leader sequence-derived (VL9) peptide binding and CD94/NKG2 receptor engagement, human leucocyte antigen E (HLA-E) reports cellular health to NK cells. Previous studies demonstrated a strong bias for VL9 binding by HLA-E, a preference subsequently supported by structural analyses. However, Mycobacteria tuberculosis (Mtb) infection and Rhesus cytomegalovirus-vectored SIV vaccinations revealed contexts where HLA-E and the rhesus homologue, Mamu-E, presented diverse pathogen-derived peptides to CD8+ T cells, respectively. Here we present crystal structures of HLA-E in complex with HIV and Mtb-derived peptides. We show that despite the presence of preferred primary anchor residues, HLA-E-bound peptides can adopt alternative conformations within the peptide binding groove. Furthermore, combined structural and mutagenesis analyses illustrate a greater tolerance for hydrophobic and polar residues in the primary pockets than previously appreciated. Finally, biochemical studies reveal HLA-E peptide binding and exchange characteristics with potential relevance to its alternative antigen presenting function in vivo.

Original publication

DOI

10.1038/s41467-018-05459-z

Type

Journal article

Journal

Nat Commun

Publication Date

07/08/2018

Volume

9

Keywords

Animals, Antigen Presentation, CD8-Positive T-Lymphocytes, Cytomegalovirus, Enzyme-Linked Immunosorbent Assay, Epitopes, HEK293 Cells, Histocompatibility Antigens Class I, Humans, Killer Cells, Natural, Macaca mulatta, Mycobacterium tuberculosis, Peptides, Protein Binding, Protein Conformation, Simian Immunodeficiency Virus